Lee Fairlie to Infant, Newborn
This is a "connection" page, showing publications Lee Fairlie has written about Infant, Newborn.
Connection Strength
0,694
-
Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV. J Acquir Immune Defic Syndr. 2024 Oct; 97(2):150-155.
Score: 0,171
-
Burden of Lassa fever disease in pregnant women and children and options for prevention. Vaccine. 2025 Jan 01; 43(Pt 1):126479.
Score: 0,043
-
Characterizing HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial. J Acquir Immune Defic Syndr. 2024 Aug; 96(4):385-392.
Score: 0,042
-
Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trial. AIDS. 2024 07 15; 38(9):1304-1313.
Score: 0,041
-
Obstetric and neonatal outcomes in South Africa. Vaccine. 2024 Feb 27; 42(6):1352-1362.
Score: 0,041
-
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus. N Engl J Med. 2023 Jul 20; 389(3):215-227.
Score: 0,039
-
Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial. BMC Infect Dis. 2022 Jul 20; 22(1):634.
Score: 0,037
-
Approaches to accelerating the study of new antiretrovirals in pregnancy. J Int AIDS Soc. 2022 07; 25 Suppl 2:e25916.
Score: 0,036
-
Pregnancy Outcomes of Women Conceiving on Antiretroviral Therapy (ART) Compared to Those Commenced on ART During Pregnancy. Clin Infect Dis. 2021 07 15; 73(2):e312-e320.
Score: 0,034
-
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2021 04 03; 397(10281):1276-1292.
Score: 0,033
-
Assessing pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results from a systematic chart review. PLoS One. 2021; 16(3):e0248423.
Score: 0,033
-
Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006-2017. Pediatr Infect Dis J. 2020 02; 39(2):127-133.
Score: 0,031
-
Neurodevelopmental delay: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2019 12 10; 37(52):7623-7641.
Score: 0,031
-
Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis. AIDS. 2019 12 01; 33(15):2403-2413.
Score: 0,030
-
What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies. Pediatr Infect Dis J. 2019 04; 38(4):400-405.
Score: 0,029
-
Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children. Pediatr Pulmonol. 2016 Feb; 51(2):157-64.
Score: 0,022